The share price will bounce back later this month when the deal is signed with the aussie telehealth company and then europe and china, USA is too risk adverse apparently, too worried of being sued
- Forums
- ASX - By Stock
- RAP
- Ann: Update on US FDA De Novo Classification Request
Ann: Update on US FDA De Novo Classification Request, page-57
-
- There are more pages in this discussion • 261 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)